NewslettersHuman Immunology NewsProstate Cell NewsProstate Cancer Immunotherapy: Improving Clinical Outcomes With a Multi-Pronged ApproachBy Bob - September 22, 2023089Scientists provide a summary of the status of immunotherapy in treating prostate cancer, with a discussion of multiple immune modalities, including vaccines, adoptively transferred T cells, and bispecific T cell engagers.[Cell Reports Medicine]Full ArticleGraphical Abstract